Skip to main content
MANIFOLD
By end of 2030, will AI therapy-matching be the main intake path for new mental-health patients in a developed country?
3
Ṁ100Ṁ38
2030
46%
chance

Resolves YES if, by Dec 31 2030, in at least one developed country (OECD member), a product or framework meeting ALL THREE criteria below is the intake path for at least 70% of people newly entering mental-health care.

Criterion (a): it parses a large corpus of the user's own text (journals, messages, past writing), not a single intake questionnaire. Criterion (b): it infers their ideal therapeutic modality (e.g. CBT, psychodynamic, DBT, IFS) rather than offering generic supportive chat. Criterion (c): it operates in hybrid with a licensed human practitioner, not as a standalone chatbot.

Current-style "AI therapy chatbots" (ChatGPT-as-therapist, Woebot/Wysa-style supportive apps) do NOT count. This market is specifically about modality-matching plus human handoff becoming the default front door to care.

Resolution source priority: first, a national health-system statistic or government report; second, a recognized industry or academic report (OECD, APA, Lancet Psychiatry, CB Insights or equivalent); third, failing any hard figure, my good-faith judgment on whether the 70% / standard-intake bar is clearly met. I will not resolve YES on anecdote alone.

Resolves NO otherwise, including if such products exist but remain niche or lack the licensed-human component.

Background (not a resolution condition): I expect public sentiment toward AI to remain pessimistic-but-used. A broad collapse in AI usage would make YES unlikely but is not itself a trigger.

Get
Ṁ1,000
to start trading!